Gracell Bio
formerly Gracell BiotechnologiesAcquiredGracell Bio is a biotech company in Shanghai, China, founded in 2017. It has raised $150.0M across 1 round, most recently a $150.0M Private Equity in August 2023.
Pioneering Next Generation CAR-T Therapies
- Headquarters
- Shanghai, Shanghai
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- gracellbio.com
- Total Funding
- $150.0M
- Last Round
- $150.0M Private EquityAug 2023
- Rounds
- 1
- Acquisition Date
- Dec 2023
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
Gracell is a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative cell therapies that address major industry challenges and unmet medical needs in cancer and autoimmune disease. It aims to disrupt conventional CAR-T approaches with its FasTCAR and TruUCAR technology platforms and SMART CART module. FasTCAR uses next-day manufacturing to generate younger, less exhausted CAR-T cells, TruUCAR explores off-the-shelf allogeneic therapies, and SMART CART is designed to tackle solid tumors.
Summary
It lists 11–50 employees. It has raised $150.0M in total across 1 round, most recently a $150.0M Private Equity round in Aug 2023. Investors include AstraZeneca, Vivo Capital and Pivotal Life Sciences.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Dec 2023
Sign up to see all 2 events
Funding: Private Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gracell-bio"><img src="https://indexed.vc/api/badge/company/gracell-bio" alt="Gracell Bio on Indexed.vc" width="260" height="76" /></a>
